LabCorp plans to acquire all of Sequenom's outstanding stock for $2.40 per share.
Agilent received notice of an unsolicited mini-tender offer by TRC Capital to purchase up to 2.5 million shares of Agilent's shares at a discount to market price.
Foundation Medicine shareholders tendered a total of nearly 18.8 million shares of common stock.
Roche said that based on preliminary results, Foundation Medicine shareholders tendered a total of 17.5 million shares, not including 1.9 million shares that were tendered by notice of guaranteed delivery.
Roche will acquire a majority stake in Foundation Medicine and directly invest in R&D.
The offer for 15.6 million shares of Foundation's common stock at $50 per share has been extended to midnight EST at the end of the day April 6.
Intrexon seeks to buy the remaining 49 percent stake in the firm, which creates animal models of human diseases in miniature pigs.
NEW YORK (GenomeWeb News) – BGI said today that it has extended its cash tender offer for Complete Genomics until 11:59 PM EDT, March 14.
NEW YORK (GenomeWeb News) – BGI-Shenzhen said late on Wednesday that it has again extended its cash tender offer for Complete Genomics.
NEW YORK (GenomeWeb News) – BGI-Shenzhen has again extended its cash tender offer for Complete Genomics, the firm said Friday.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.